Moderna (MRNA) PT Raised to $125 at Jefferies

March 28, 2024 9:02 AM EDT Send to a Friend
Jefferies analyst Michael Yee raised the price target on Moderna (NASDAQ: MRNA) to $125.00 (from $115.00) while maintaining a Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login